Search

everythinglearnresearchcommunity

for

Search:↓

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Treating gum disease and stress may help improve alopecia.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Higher IL-21 levels may help predict alopecia areata activity.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The document concludes that specialized hair transplant techniques can be effective, with varying success rates depending on the donor area and patient factors.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Patients with lichen planopilaris have a higher risk of heart disease.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Using neurohormones to control keratin can lead to new skin disease treatments.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Neurohormones help control skin health and could treat skin disorders.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.